SEC Form 4 · accession 0001493152-26-028608
Tonix Pharmaceuticals Holding Corp. · TNXP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Carolyn E. Taylor
Director
Period of report
Jun 12, 2026
Accepted (ET)
Jun 15, 2026 · 7:00 am EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001430306
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.001 par value | Jun 12, 2026 | P | 1,415 | $10.55 | A | 1,833 | D |
Table II — derivative securities
No Table II lines on this filing.